Treating Drug-resistant Tuberculosis Infection: No More Excuses
Clin Infect Dis
.
2021 May 18;72(10):1716-1718.
doi: 10.1093/cid/ciaa328.
Authors
Anja Reuter
1
,
Jennifer Furin
2
Affiliations
1
Médecins Sans Frontières, Khayelitsha, Cape Town, South Africa.
2
Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
PMID:
32266941
DOI:
10.1093/cid/ciaa328
No abstract available
Keywords:
Pakistan; fluoroquinolones; resistance; safety; suffering.
Publication types
Editorial
Comment
MeSH terms
Antitubercular Agents / therapeutic use
Humans
Tuberculosis, Multidrug-Resistant* / drug therapy
Substances
Antitubercular Agents